I- For the treatment group:
A- Medical History Questionnaire will be filled by the patient to exclude the presence of any systemic condition.
B- Clinical Examination:
Proper examination of the oral structures including;
* Teeth will be examined for caries, fracture or missing teeth
* Gingival tissues will be examined for gingivitis, periodontitis, attachment loss, gingival recession, oral lesions and the nature of the gingival biotype.
* Thorough intraoral examination is needed to evaluate the need for referral for consultation or intervention before the initiation of treatment.
C- Diagnosis:
* The patient is checked to fulfil the inclusion criteria.
* A clinical visualized treatment outcome (VTO) will be done by asking the patient to bite in an advanced position and check the outcome of this advancement on the patient"s profile. Patients with positive results (better profiles were achieved upon advancement) are included in the study.
* Full set of records (including standardized Lateral Cephalograms) will be taken for every 8 patient as part of the routine procedure for treatment of patients in the outpatient clinic of the Orthodontic Department, Cairo University.
D- Clinical Procedures:
After taking upper and lower impressions, the impressions are then poured into hard stone that are then digitally scanned using 3D laboratory scanner (3Shape R500 Lab Scanner).
Designing the appliance is done on upper and lower virtual models (using 3Shape Appliance Designer). The appliance covers the upper and lower dental arches with lingual horizontal rectangular attachments to increase the retention.
Buccal triangular ramps for mandibular advancement are designed. They are positioned buccal to the upper and lower posterior segments with a lock to ensure the desired mandibular advancement.
3D printing of the appliance is then done using 3D printer (Dent2-Mogassam) with biocompatible resin material (NextDent Resin OrthoRigid).
Post curing using ultraviolet light for 30min using postcuring unit (Postcuring- Mogassam).
The appliance is then delivered to the patient and instructions are given. Follow up every 4 weeks for 8 months or edge to edge occlusion (the sooner) and then full records taken including Lateral Cephalogram.
II- For the Control group
* The subjects should be fulfilling the previously mentioned inclusion criteria and should sign the informed consent of agreement to be recruited in the study.
* According to the randomization sheet, the patients allocated to the control group will be immediately referred for the uptake of a Lateral Cephalogram which will be considered (T1) without any treatment procedures.
* A "no treatment" phase of 8 months will be carried out through which the patients will be followed up to monitor any factor that might have occurred to exclude the patient from the study.
* Another Lateral Cephalogram will be taken after 8 months (T2).
* T2 images are to be considered the initial diagnostic images for the patient. The patients will be then assessed and treatment will be provided for each patient as required.
